Biotech specialized in precision medicine, our mission is to bring innovative therapeutic and diagnostic solutions to treat resistant and metastasis cancer.. .
Perfekt, din titel innehåller mellan 10 och 70 tecken.
Bra, din metabeskrivning innehåller mellan 70 och 160 tecken.
Vi hittade 12 bilder på denna webbsida. 2 alt attribut är tomma eller saknas. Lägg till alternativ text så att sökmotorer enklare kan förstå innehållet i dina bilder.
Bra, den här sidans förhållande mellan text till HTML-kod är högre än 15, men lägre än 25 procent.
Perfekt, inga Flash-innehåll har upptäckts på denna sida.
Bra, vi upptäckte inga Iframes på den här sidan.
| locale | en_GB |
|---|---|
| locale:alternate | fr_FR |
| type | website |
| title | Oncodesign Precision Medicine |
| description | Biotech specialized in precision medicine, our mission is to bring innovative therapeutic and diagnostic solutions to treat resistant and metastasis cancer. |
| url | http://www.oncodesign.com/ |
| site_name | Oncodesign Precision Medicine |
| image | https://www.oncodesign.com/wp-content/uploads/2022/09/oncodesign-pm-home-intro.png |
| image:width | 599 |
| image:height | 493 |
| image:type | image/png |
Interna Länkar 95.83%
Externa Länkar [Passing Juice 4.17%]
Externa Länkar [noFollow 0%]
| Anchor | Link | Typ | Juice |
|---|---|---|---|
| Learn more | https://oncodesign-services.com/ | Externa | Passing Juice |
| Our pipeline | https://oncodesign.com/our-pipeline/ | Interna | Passing Juice |
| Partnering | https://oncodesign.com/our-pipeline/partnering/ | Interna | Passing Juice |
| Our innovation technologies | https://oncodesign.com/our-innovation-technologies/ | Interna | Passing Juice |
| OncoSNIPER | https://oncodesign.com/our-innovation-technologies/oncosniper/ | Interna | Passing Juice |
| Nanocyclix | https://oncodesign.com/our-innovation-technologies/nanocyclix/ | Interna | Passing Juice |
| PROMETHE | https://oncodesign.com/our-innovation-technologies/theranostics/ | Interna | Passing Juice |
| Investors | https://oncodesign.com/investors/ | Interna | Passing Juice |
| Message from the chairman | https://oncodesign.com/investors/message-from-the-chairman/ | Interna | Passing Juice |
| Regulated information [FR] | https://oncodesign.com/investors/regulated-information/ | Interna | Passing Juice |
| Press Release | https://oncodesign.com/press-release/ | Interna | Passing Juice |
| General Meetings [FR] | https://oncodesign.com/fr/investisseurs/assemblee-generale/ | Interna | Passing Juice |
| About us | https://oncodesign.com/about-us/ | Interna | Passing Juice |
| Latest news | https://oncodesign.com/about-us/news/ | Interna | Passing Juice |
| Our history | https://oncodesign.com/about-us/our-history/ | Interna | Passing Juice |
| Management | https://oncodesign.com/fr/a-propos/management-2/ | Interna | Passing Juice |
| Our HR policy | https://oncodesign.com/about-us/careers/ | Interna | Passing Juice |
| Our CSR approach | https://oncodesign.com/about-us/our-csr-approach/ | Interna | Passing Juice |
| FederAidd | https://oncodesign.com/about-us/federaidd/ | Interna | Passing Juice |
| Contact us | https://oncodesign.com/contact-us/ | Interna | Passing Juice |
| OPM announces a 6 million euros bank financing | https://oncodesign.com/opm-announces-a-6-million-euros-bank-financing/ | Interna | Passing Juice |
| OPM announces positive interim results of its Phase 1 study | https://oncodesign.com/opm-announces-positive-interim-results-of-its-phas | Interna | Passing Juice |
| Legal notice | https://oncodesign.com/legal-notice/ | Interna | Passing Juice |
| Personal data policy | https://oncodesign.com/personal-data-policy/ | Interna | Passing Juice |
| Nyckelord | Innehåll | Titel | Nyckelord | Beskrivning | Rubriker |
|---|---|---|---|---|---|
| news | 5 |  |
|
|
 |
| therapeutic | 5 | |
|
|
|
| opm | 4 | |
|
|
|
| learn | 4 | |
|
|
|
| more | 4 | |
|
|
|
| innovative | 3 | |
|
|
|
| pipeline | 3 | |
|
|
|
| read | 3 | |
|
|
|
| innovation | 3 | |
|
|
|
| technologies | 3 | |
|
|
|
| oncodesign | 3 | |
|
|
|
| investors | 3 | |
|
|
|
14 Längd
Perfekt. Din deklarerade teckenuppsättning är UTF-8.
Bra. Ditt angivna språk är EN. 
Bra! Vi har inte hittat några föråldrad HTML taggar i din HTML.
Bra, din webbplats har en favicon.
Bra! Ingen e-postadress har hittats i klartext.
Denna sida drar inte nytta utav Dublin Core.
Vi kunde inte hitta CSS för utskrifter.
oncodesign precision medicine, to find the best therapeutic path, our pipeline, our technologies, opm announces a 6 million euros bank financing, opm announces positive interim results of its phase 1 study, attention javascript est désactivé sur votre poste. ce site nécessite l'activation de javascript pour fonctionner correctement., our science, news, newsletter, therapeutic, solutions, patient, announces, technologies, first--class, patients, science, pipeline, news, nanocyclix, october, discovery, opportunities, programs, highly, investors, benefit, also, several, innovative, precision, best--class, services, medicine, javascript, policy, covering, oncosniper, oncodesign, goals, attention, shared, read, drug, activities, latest, more, promethe, innovation, opm, explore, cro, all, areas, model, dedicated, learn, newsletter, technological, oncodesign.com.
